摩熵化学
数据开放平台 数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-fluorophenyl N-butyl carbamate

中文名称
——
中文别名
——
英文名称
4-fluorophenyl N-butyl carbamate
英文别名
butyl (4-fluorophenyl)carbamate;Carbamic acid, 4-fluorophenyl-, butyl ester;butyl N-(4-fluorophenyl)carbamate
4-fluorophenyl N-butyl carbamate化学式
CAS
——
化学式
C11H14FNO2
mdl
——
分子量
211.236
InChiKey
YLDKMTJXAZGFGB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.4
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.36
  • 拓扑面积:
    38.3
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    tetrabutoxytitanium二氧化碳4-氟苯胺乙腈 为溶剂, 20.0~180.0 ℃ 、5.0 MPa 条件下, 反应 0.33h, 以84%的产率得到4-fluorophenyl N-butyl carbamate
    参考文献:
    名称:
    使用钛氧化物从二氧化碳和胺中无卤合成氨基甲酸酯
    摘要:
    研究了在Ti(OR)4(R = n Bu(1),Me(2),Et(3),n Pr(4))存在下从胺和二氧化碳直接合成氨基甲酸酯的方法。在二氧化碳(5 MPa)存在下,苯胺与正丁醇钛(1)反应,在20分钟内以几乎定量的产率(99%)得到相应的正丁基N-苯基氨基甲酸酯(BPC)。此外,在脱水过程中与正丁醇反应后可再生1。恢复的1 然后可以在后续反应中重复使用。
    DOI:
    10.1002/asia.201700465
点击查看最新优质反应信息

文献信息

  • PRODUCTION METHOD OF CARBAMIC ACID ESTER
    申请人:NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    公开号:US20190185420A1
    公开(公告)日:2019-06-20
    A method of production of carbamic acid ester has a high yield and high selectivity and is superior in economy. The method of production of a carbamic acid ester includes reacting an amine, carbon dioxide, and an alkoxysilane compound in the presence of a catalyst containing a zinc compound or an alkali metal compound or in the presence of an ionic liquid. A carbamic acid ester is produced, for example by reacting aniline, carbon dioxide, and tetramethoxysilane at a temperature of 150 to 180° C. in the presence of zinc acetate and 2,2′-bipyridine.
    一种生产氨基甲酸酯的方法具有高产率和高选择性,并在经济上优越。生产氨基甲酸酯的方法包括在催化剂的存在下,将胺、二氧化碳和烷氧基硅烷化合物反应,所述催化剂含有化合物或碱属化合物或存在于离子液体中。例如,通过在150至180°C的温度下,在醋酸2,2'-联吡啶的存在下,将苯胺二氧化碳和四甲氧基硅烷反应,可以生产氨基甲酸酯。
  • Modulation of anxiety through blockade of anandamide hydrolysis
    申请人:The Regents of the University of California
    公开号:US20040127518A1
    公开(公告)日:2004-07-01
    Fatty acid amide hydrolase inhibitors of the Formula: 1 are provided wherein X is NH, CH 2 , O, or S; Q is O or S; Z is O or N; R is an aromatic moiety selected from the group consisting of substituted or unsubstituted aryl; substituted or unsubstituted biphenylyl, substituted or unsubstituted naphthyl, and substituted or unsubstituted phenyl; substituted or unsubstituted terphenylyl; substituted or unsubstituted cycloalkyl, heteroaryl, or alkyl; and R 1 and R 2 are independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, and substituted or unsubstituted phenyl, substituted or unsubstituted biphenylyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; with the proviso that if Z is O, one of R 1 and R 2 is absent, and that if Z is N, optionally R 1 and R 2 may optionally be taken together to form a substituted or unsubstituted N-heterocycle or substituted or unsubstituted heteroaryl with the N atom to which they are each attached. Pharmaceutical compositions comprising the compounds of Formula I and methods of using them to inhibit FAAH and/or treat appetite disorders, glaucoma, pain, insomnia, and neurological and psychological disorders including anxiety disorders, epilepsy, and depression are provided.
    本发明提供了公式1中X为NH,CH2,O或S;Q为O或S;Z为O或N;R为从取代或未取代芳基;取代或未取代联苯基;取代或未取代基;取代或未取代苯基;取代或未取代三苯基基;取代或未取代环烷基,杂环芳基或烷基中选择的芳香基;R1和R2分别独立地选择从H,取代或未取代烷基,取代或未取代杂环烷基和取代或未取代苯基,取代或未取代联苯基,取代或未取代芳基和取代或未取代杂环芳基的群中选择;但是如果Z为O,则R1和R2中的一个不存在,如果Z为N,则R1和R2可以选择性地一起形成取代或未取代的N-杂环或取代或未取代的杂环芳基,与它们各自连接的N原子。本发明还提供了包括公式I中化合物的制药组合物以及使用它们来抑制FAAH和/或治疗食欲障碍,青光眼,疼痛,失眠和神经心理障碍,包括焦虑症,癫痫和抑郁症的方法。
  • MODULATION OF ANXIETY THROUGH BLOCKADE OF ANANDAMIDE HYDROLYSIS
    申请人:Piomelli Daniele
    公开号:US20120010283A1
    公开(公告)日:2012-01-12
    Fatty acid amide hydrolase inhibitors of the Formula: are provided wherein X is NH, CH 2 , O, or S; Q is O or S; Z is O or N; R is an aromatic moiety selected from the group consisting of substituted or unsubstituted aryl; substituted or unsubstituted biphenylyl, substituted or unsubstituted naphthyl, and substituted or unsubstituted phenyl; substituted or unsubstituted terphenylyl; substituted or unsubstituted cycloalkyl, heteroaryl, or alkyl; and R 1 and R 2 are independently selected from the group consisting of H, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, and substituted or unsubstituted phenyl, substituted or unsubstituted biphenylyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; with the proviso that if Z is O, one of R 1 and R 2 is absent, and that if Z is N, optionally R 1 and R 2 may optionally be taken together to form a substituted or unsubstituted N-heterocycle or substituted or unsubstituted heteroaryl with the N atom to which they are each attached. Pharmaceutical compositions comprising the compounds of Formula I and methods of using them to inhibit FAAH and/or treat appetite disorders, glaucoma, pain, insomnia, and neurological and psychological disorders including anxiety disorders, epilepsy, and depression are provided.
    提供了公式为的脂肪酸酰胺解酶抑制剂:其中X为NH,CH2,O或S;Q为O或S;Z为O或N;R为从取代或未取代芳基;取代或未取代联苯基;取代或未取代基;取代或未取代苯基;取代或未取代三苯基基;取代或未取代环烷基,杂环芳基或烷基中选择的芳香基;R1和R2分别选择自H,取代或未取代烷基,取代或未取代杂环烷基,取代或未取代苯基,取代或未取代联苯基,取代或未取代芳基和取代或未取代杂环芳基的群中;但是如果Z为O,则R1和R2中的一个不存在,如果Z为N,则可选地将R1和R2结合在一起形成取代或未取代的N-杂环或取代或未取代的杂环芳基,与它们各自连接的N原子。提供了包含公式I化合物的制药组合物以及使用它们来抑制FAAH和/或治疗食欲障碍,青光眼,疼痛,失眠以及神经和心理障碍,包括焦虑症,癫痫和抑郁症的方法。
  • METHOD FOR PRODUCING CARBAMIC ACID ESTER
    申请人:National Institute of Advanced Industrial Science and Technology
    公开号:EP3508473A1
    公开(公告)日:2019-07-10
    A method of production of carbamic acid ester has a high yield and high selectivity and is superior in economy. The method of production of a carbamic acid ester includes reacting an amine, carbon dioxide, and an alkoxysilane compound in the presence of a catalyst containing a zinc compound or an alkali metal compound or in the presence of an ionic liquid. A carbamic acid ester is produced, for example by reacting aniline, carbon dioxide, and tetramethoxysilane at a temperature of 150 to 180°C in the presence of zinc acetate and 2,2'-bipyridine.
    一种生产氨基甲酸酯的方法具有高产率和高选择性,而且经济性更好。氨基甲酸酯的生产方法包括在含有化合物或碱属化合物的催化剂存在下,或在离子液体存在下,使胺、二氧化碳和烷氧基硅烷化合物发生反应。例如,在乙酸2,2'-联吡啶的存在下,苯胺二氧化碳和四甲氧基硅烷在 150 至 180°C 的温度下发生反应,即可制得氨基甲酸酯。
  • Production method of carbamic acid ester
    申请人:NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY
    公开号:US10752579B2
    公开(公告)日:2020-08-25
    A method of production of carbamic acid ester has a high yield and high selectivity and is superior in economy. The method of production of a carbamic acid ester includes reacting an amine, carbon dioxide, and an alkoxysilane compound in the presence of a catalyst containing a zinc compound or an alkali metal compound or in the presence of an ionic liquid. A carbamic acid ester is produced, for example by reacting aniline, carbon dioxide, and tetramethoxysilane at a temperature of 150 to 180° C. in the presence of zinc acetate and 2,2′-bipyridine.
    一种生产氨基甲酸酯的方法具有高产率和高选择性,而且经济性更好。氨基甲酸酯的生产方法包括在含有化合物或碱属化合物的催化剂存在下,或在离子液体存在下,使胺、二氧化碳和烷氧基硅烷化合物发生反应。例如,在乙酸和 2,2′-联吡啶的存在下,苯胺二氧化碳和四甲氧基硅烷在 150 至 180 摄氏度的温度下反应,可制得氨基甲酸酯。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫